logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9610270 B1

PDFFull Text
Date of Patent:
Apr. 04, 2017

Filed:

Oct. 23, 2012

Therapy for transthyretin-associated amyloidosis

Applicant:

Som Innovation Biotech, S.l., Barcelona, ES;

Inventors:

Marc Centellas Casado, Barcelona, ES;

Raúl Insa Boronat, Barcelona, ES;

Nuria Reig Bolaño, Barcelona, ES;

Núria Gavaldà Batalla, Barcelona, ES;

Assignee:

SOM INNOVATION BIOTECH, S.L., Barcelona, ES;

Attorney:

Jenkins, Wilson, Taylor & Hunt

Primary Examiner:

Raymond Henley, Iii

Int. Cl.
CPC ...
A61K 31/42 (2006.01); A61K 31/165 (2006.01); A61K 31/12 (2006.01); A61K 31/198 (2006.01); A61K 45/06 (2006.01); A61K 31/353 (2006.01); A61K 31/423 (2006.01); A61K 31/603 (2006.01); A61K 31/192 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A61K 31/12 (2013.01); A61K 31/192 (2013.01); A61K 31/353 (2013.01); A61K 31/423 (2013.01); A61K 31/603 (2013.01); A61K 45/06 (2013.01);
Abstract

It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate.

Find Patent Forward Citations

Centellas Casado, Marc. (2017). Therapy for transthyretin-associated amyloidosis (U.S. Patent No. 9610270). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9610270

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…